We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects (SHIELD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00740064
Recruitment Status : Unknown
Verified January 2009 by Denver Infectious Disease Consultants, PLLC.
Recruitment status was:  Active, not recruiting
First Posted : August 22, 2008
Last Update Posted : January 28, 2009
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Denver Infectious Disease Consultants, PLLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : August 2009
  Estimated Study Completion Date : November 2009